Records recently released by the governor’s office indicate Indiana spent another $100,000 on pentobarbital used in October, pushing overall execution drug costs to at least $1.275 million. The paperwork came forward after extended public records requests and ongoing legal disputes.
According to the inventory log, the drugs remained in state custody for varying periods before use or disposal, prompting new questions about storage and supervision. Public defender Joanna Green said the records imply the drugs “sat on the shelf for a very long time,” especially if compounded.
Drug Purchases, Storage Timeline and Inventory Details
Documents show Indiana acquired 12 vials of pentobarbital on Feb. 27, 2024, at a cost of $900,000. Half were later used in December, while the remaining vials stayed in storage for months. That timeline runs well past the 90-day shelf life officials referenced earlier.
Then in April 2025, six more vials were purchased for $275,000, restoring the inventory to 12. Six were used in May, leaving two unexpired doses afterward. A separate single dose cost $100,000 ahead of the October execution.
Earlier statements from Gov. Mike Braun acknowledged spending more than $1 million on execution drugs within roughly a year, including about $600,000 that expired unused. The inventory log now maps out when supplies were bought, stored, and moved.
Protocol Questions and Storage Concerns
Public defender Joanna Green said the inventory entries raise concerns about whether correction officials followed their own procedures. She pointed to records showing six vials removed for one execution and four later returned, calling that sequence difficult to reconcile with standard preparation steps.
Green explained that the protocol described to defense attorneys requires three syringe sets, each containing two syringes filled with 2.5 grams. Under that setup, six vials would be necessary. “It appears they didn’t fill the two backup sets,” she said.
Storage conditions have also drawn scrutiny. Department logs show several winter days when temperatures dropped to 62 degrees, outside recommended ranges. Experts have testified that time, handling, and storage conditions can affect potency, especially when compounded drugs are involved.
Transparency, Secrecy and Legislative Debate
State law shields the identity of execution drug suppliers from public disclosure, limiting access through court proceedings or open records requests. Journalists are also barred from witnessing executions unless invited by the condemned person. A federal lawsuit challenging that restriction remains pending.
Questions about sourcing and oversight have intensified since Indiana resumed executions after a 15-year pause. Five men remain on death row in Michigan City, though one has been deemed incompetent. None are currently scheduled for execution.
During the 2026 legislative session, some lawmakers proposed allowing firing squad executions if lethal injection drugs became unavailable. Those bills did not advance. Still, debate continues over cost, transparency, and whether current safeguards meet public expectations for accountability.
Endnote
Indiana’s return to capital punishment continues to spark debate outside the courtroom. Some lawmakers say the state needs dependable execution procedures in place, while others raise concerns about growing costs and how little the public is allowed to see.
Attorneys, health professionals, and policymakers will likely continue seeking clearer answers about sourcing and oversight. “When information is limited, questions only grow,” a defense lawyer said recently. At this point, any future executions depend on court calendars and decisions still in motion.